While previous studies have shown that Zyban can help up to 30 percent of average smokers to quit for at least a year, the medication was never tested on hardcore smokers, defined as those who can't stop smoking despite being sick with chronic obstructive pulmonary disease (COPD).

But new research conducted by scientists at the University of California, Los Angeles (UCLA) found that when hardcore smokers take Zyban, their chances of quitting increased from 9 percent to 16 percent.

"They almost doubled their chances of giving up. That's about the same chance as smokers in general," said Dr. Donald P. Tashkin, a professor of pulmonology at UCLA and leader of the study.

The study's findings were presented at the Sept. 1 World Congress on Lung Health.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:
Comment: (limit 200 words)
Enter this word (help):	Change

GUIDELINES: 
To keep this feature useful for everyone, please:

1. Keep it clean, courteous, focused, and on-topic. Comments are meant for thoughtful discussion of the article published above.
   
   
2. Do not post personal requests for help or general promotions for your organization (Get help).
   
   
3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.